IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder.

Trial Profile

IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Sep 2012

At a glance

  • Drugs Antipsychotics; Quetiapine
  • Indications Bipolar disorders; Schizophrenia
  • Focus Therapeutic Use
  • Acronyms IBIS
  • Sponsors AstraZeneca
  • Most Recent Events

    • 04 Sep 2012 Planned End Date changed from 1 Aug 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
    • 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Aug 2012 Planned End Date changed from 1 Jul 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top